SSY GROUP (02005): Acetylaminophenol tablets approved by the National Medical Products Administration for new 0.5g specification.
Sinopharm Group (02005) announced that the group's paracetamol tablets have been approved by the China National Medical Products Administration...
SSY GROUP (02005) announced that the group's paracetamol tablets have been approved by the National Medical Products Administration of China (NMPA) for a new 0.5g specification, and both the 0.3g and 0.5g paracetamol tablets have been approved by the NMPA for generic drug quality and therapeutic efficacy consistency evaluation.
Paracetamol tablets are mainly used for fever caused by common cold or influenza, and also used to relieve mild to moderate pain.
Related Articles

HK Stock Market Move | BLACK SESAME(02533) opens higher by more than 5%, Huashan A2000 chip passes US review.

CITIC SEC: The tourism market starts off strong in 2026, and duty-free shopping on outlying islands experiences a robust recovery.

Guotai Haitong: raised the target price of DUALITYBIO-B (09606) to 455.56 Hong Kong dollars and maintained a buy rating.
HK Stock Market Move | BLACK SESAME(02533) opens higher by more than 5%, Huashan A2000 chip passes US review.

CITIC SEC: The tourism market starts off strong in 2026, and duty-free shopping on outlying islands experiences a robust recovery.

Guotai Haitong: raised the target price of DUALITYBIO-B (09606) to 455.56 Hong Kong dollars and maintained a buy rating.

RECOMMEND

Hong Kong Listed Companies’ Return To A Shares Heats Up As New “H To Shenzhen A” Case Emerges
05/01/2026

What Do The Top Ten Biopharma IPOs Of 2025 Tell Us?
05/01/2026

Asia’s Stock Markets Deliver A Strong 2025: Korea Soars 76%, Japan Tops Bubble‑Era Peak, Indonesia Records Best Year In 11 Years
05/01/2026


